Breathonix
Breathonix offers rapid, non-invasive breath tests that detect diseases such as COVID-19, diabetes markers, and early-stage lung cancer in seconds to minutes. It combines portable breath analyzers and mass spectrometry with machine learning models that analyze volatile organic compounds (VOCs) from exhaled breath to identify disease signatures. The company operates as a B2B SaaS and device provider for healthcare providers, clinical laboratories, and point-of-care settings, with products like the BreFence Go and MetaDR portable analyzer. Breathonix holds regulatory approvals in multiple regions, maintains FDA registration and patents in breath testing technology, and runs clinical trials to expand its diagnostic indications. Its platform targets mass screening and home monitoring use cases through subscription software and integrated hardware deployments.
Breathonix
Breathonix offers rapid, non-invasive breath tests that detect diseases such as COVID-19, diabetes markers, and early-stage lung cancer in seconds to minutes. It combines portable breath analyzers and mass spectrometry with machine learning models that analyze volatile organic compounds (VOCs) from exhaled breath to identify disease signatures. The company operates as a B2B SaaS and device provider for healthcare providers, clinical laboratories, and point-of-care settings, with products like the BreFence Go and MetaDR portable analyzer. Breathonix holds regulatory approvals in multiple regions, maintains FDA registration and patents in breath testing technology, and runs clinical trials to expand its diagnostic indications. Its platform targets mass screening and home monitoring use cases through subscription software and integrated hardware deployments.